glp 1 receptor agonist drugs The New Frontiers | Exploring the multifaceted

Additionally, these therapies can cut cardiovascular risk by 20%, offering metabolic advantages that go hand-in-hand with the weight loss outcomes

Gallego-Colon, W

Cardiovascular protection: Some GLP-1 medications have been shown to reduce the risk of major cardiovascular events such as heart attack, stroke, and cardiovascular death in people with type 2 diabetes, particularly those with existing cardiovascular disease or multiple risk factors

Our findings provide important information for designing new GLP-1-based therapy strategies in the treatment of type 2 diabetes

The registration requirement adds friction that some researchers prefer to avoid, especially when comparison shopping across multiple vendors

2016, Sun et al